Drug Trial Radar · NCT00334633
Treatment of Bacterial Vaginosis (BV) With Tinidazole
Last checked: Nov 19, 2026Latest source record: Dec 2, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
593
Actual
Start
Nov 2004
Primary completion
Dec 2009
Study completion Dec 2009
Sponsor
- Lead sponsor
- University of Alabama at BirminghamAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Allergy and Infectious Diseases (NIAID)
- First posted
- Jun 8, 2006
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
We are trying to determine if treatment of bacterial vaginosis with tinidazole is better than treatment with metronidazole
Conditions
- Bacterial Vaginosis
Interventions
tinidazole, metronidazoleDrug
Tinidazole 500 mg bid; Tinidazole 1mg bid; Metronidazole 500mg bid
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cure of Bacterial VaginosisTime frame: one month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Jefferson County Department of Health STD Clinic
Birmingham, Alabama
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.